Comprehensive Coverage

Major pipelines based on MSCs and iPSCs.

aCGT has a broad range of cellular and cosmetic ingredient products based on various stem cells, i.e. Umbilical Cord-derived Mesenchymal Stem Cells (UCMSC) and induced pluripotent stem cells (iPSC).

UCMSCs have a wide range of applications in immunomodulation and tissue regeneration. aCGT’s UCMSC product is targeting multiple indications, and NMPA-approved clinical trials are ongoing.

Various types of cells derived from iPSC have excellent performance in tissue repair/regeneration or pathogenic cell killing. aCGT has been developing various iPSC-derived cellular products, which are pending IND submission or approval.

aCGT’s existing products (e.g., UCMSC, iNPC, CAR-iNK) have a wide range of extendability to some other indications, making it easier to expand indications/pipelines at low cost.

Besides, as a by-product of UCMSC culture and given the excellent efficacy of UCMSC against various indications, the culture supernatant and isolated exosomes serve as high-grade, extraordinarily efficacious and low-cost cosmetic raw materials.

Particular Focus

Focus on autoimmune diseases and nervous system diseases.